Combination of serum TIMP-3, CA125, and NT-proBNP in predicting ventricular remodeling in patients with heart failure following acute myocardial infarction.

Xie, Yue-Tao; Dang, Yi; Zhang, Fei-Fei; Zhang, Qian-Hui; Wu, Hai-Bo; Liu, Guang

Xie, Yue-Tao; Dang, Yi; Zhang, Fei-Fei; Zhang, Qian-Hui; Wu, Hai-Bo; Liu, Guang.

Afiliación

Xie YT; Department of Cardiology, Hebei General Hospital, Shijiazhuang, China.
Dang Y; Department of Cardiology, Hebei General Hospital, Shijiazhuang, China.
Zhang FF; Department of Cardiology, Hebei General Hospital, Shijiazhuang, China.
Zhang QH; Department of Cardiology, Hebei General Hospital, Shijiazhuang, China.
Wu HB; Department of Cardiology, Hebei General Hospital, Shijiazhuang, China.
Liu G; Department of Cardiology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.

Cardiovasc Diagn Ther ; 10(5): 1184-1191, 2020 Oct.

Article en En | MEDLINE | ID: mdl-33224742

Palabras clave

Acute myocardial infarction (AMI); N-terminal pro-brain natriuretic peptide (NT-proBNP); carbohydrate antigen CA125; heart failure; tissue inhibitor of matrix metalloproteinase 3

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cardiovasc Diagn Ther Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google